semaglutide and dramamine tirzepatide Tirzepatide (Mounjaro) In Sherman Oaks FDA Warns on Certain Forms

The GLP-1 NAION vision-loss MDL hit 146 cases on the July JPML report up 70% in two months as the GI-injury MDL heads to Rule 702 hearings September 10-18.

Stroke was thefourth leading cause of deathin the US last year, accounting for 162,600 deaths,according to preliminary data.

Safe travels and smooth blood glucose control ahead!

It is NOT intended for human or veterinary use, consumption, diagnostics, therapeutic applications, or any other use outside of controlled laboratory research

While some manufacturer suits against telehealth and compounders are falling away, multidistrict litigation (MDL) dockets tied to GLP-1 adverse-event claims are expanding rapidly